molecular diagnostics

Korean Investors Samsung to invest $10 million in US-based C2N Diagnostics

Samsung Group companies will jointly invest $10 million in C2N Diagnostics LLC, a U.S.-based company specializing in blood-based Alzheimer’s d...

Bio & Pharma Korea’s Lunit in AI-powered lung cancer diagnostics deal with AstraZeneca

Lunit Inc., a South Korean AI-powered cancer diagnostics company, has partnered with global biopharma giant AstraZeneca plc. to jointly enter the AI...

Energy KEPCO, LS Electric to co-work on predictive diagnostics solutions

Korea Electric Power Corp. (KEPCO), the South Korean state-run utility company, said on Thursday it signed a memorandum of understanding (MOU) with ...

Bio & Pharma ViGenCell obtains approval for HLA-B5801 genetic diagnostic kit for adverse reactions to gout treatment

ViGenCell, a company specializing in immunotherapy, announced on Friday that it has obtained approval from the Ministry of Food and Drug Safety (MFD...

Bio & Pharma Gencurix, Hitachi to cooperate on molecular diagnostics

South Korean biotech company Gencurix Inc. said on Tuesday that it will cooperate with Japan's Hitachi High-Tech Corporation to enter the Japanese c...

Bio & Pharma Volpara to supply cancer diagnostics SW to Intermountain Health

Lunit, a South Korean cancer diagnostics AI company, announced on Wednesday that its subsidiary Volpara Health, a New Zealand-based AI software deve...

Bio & Pharma Lunit participates in Singapore's AI diagnostic solution project

Lunit, a South Korean cancer diagnostics AI company, announced on Wednesday that it solely participates in a chest X-ray reading workflow improvemen...

Tech, Media & Telecom SK Telecom's X Caliber to enter SE Asian pet market

South Korea's SK Telecom Co. announced on Tuesday that it signed a contract to supply X Caliber, an AI-based pet diagnosis assistance solution, to t...

Bio & Pharma Lunit to supply AI cancer diagnostics to Qatar

Lunit Inc., a South Korean cancer diagnostics AI company, announced on Monday that it will provide its AI breast cancer screening solution Lunit Ins...

Tech, Media & Telecom SK Telecom's X Caliber enters N.American pet market

South Korea's SK Telecom Co. announced on Monday that it signed a distribution agreement with Canadian pet medical equipment company Nuon & Nikk...

Artificial intelligence Lunit eyes developing markets with AI cancer diagnostics

Lunit Inc., a South Korean cancer diagnostics AI company, will accelerate its inroads into developing markets grappling with inadequate cancer diagn...

Bio & Pharma Kwangdong Pharma acquires stake in Precision Bio

South Korea's Kwangdong Pharmaceutical announced on Tuesday that it signed a stock purchase agreement to acquire Precision Biosensor Inc., a company...

Bio & Pharma Noul, CDC to start Malaria diagnosis project in Kenya

South Korea's Noul Co., an in-vitro diagnostics maker and artificial intelligence (AI)-based blood and cancer diagnostic platforms company, said o...

Tech, Media & Telecom SK Telecom launches AI pet diagnostic solution in Australia

South Korea's SK Telecom Co. announced on Wednesday that it launched its AI-based pet diagnostic assistance service X Caliber in Australia and has b...

Tech, Media & Telecom SK shieldus, Yokogawa Electric Korea partner on security business

SK shieldus, the unmanned security subsidiary of SK Group, announced on Wednesday it has signed a business agreement with Yokogawa Electric Korea Co...

Bio & Pharma NGeneBio to transfer NGS tech to UAE company

South Korean medical diagnostic company NGeneBio Co. announced on Tuesday that it signed a contract with the United Arab Emirates (UAE)-based medica...

Artificial intelligence Vuno, Canon to target AI diagnostic market in Japan

South Korea's medical device startup Vuno announced on Monday that its Japanese partner M3AI signed a memorandum of understanding (MOU) with Canon M...

Bio & Pharma Genesystem enters Indian tuberculosis treatment market

Genesystem, a South Korean biotech company said on Tuesday that it will export 20 on-site tuberculosis (TB) diagnostic devices and 6,000 TB test kit...

Bio & Pharma Daewoong Pharmaceutical digitizes DB of 800 mn chemical compounds

South Korea's Daewoong Pharmaceutical announced on Monday that it has established a drug development system Daewoong AI System (DAISY) which combine...

Tech, Media & Telecom SK Telecom to enter Australian pet clinics market in H1

South Korea’s SK Telecom Co. announced on Tuesday that it has signed a commercial contract with ATX Medical Solutions, Australia's largest m...

Artificial intelligence SK Telecom to enter AI pet diagnostic market in US

South Korea’s SK Telecom Co. announced on Wednesday that it has signed with the US-based veterinary diagnostic radiology firm Vetology to laun...

Bio & Pharma Roche to use Biodyne’s tech for cervical cancer diagnostic kits

Roche, a Swiss multinational healthcare company, is set to use a South Korean company’s technology for cervical cancer diagnostic kits.Biodyne...

Bio & Pharma NGeneBio gets approval for cancer diagnostic device in Thailand

South Korean medical diagnostic company NGeneBio Co. announced on Friday that it has received approval for the sale of its in-vitro diagnostic medic...

Bio & Pharma Lunit acquires NZ-based AI diagnostics firm Volpara

South Korean medical AI company Lunit announced on Thursday that it will acquire New Zealand-based AI breast cancer diagnostics solutions company Vo...

Electronics LG Elec launches new medical monitor

LG Electronics Inc. unveiled a new medical monitor on Wednesday. This monitor boasts high brightness suitable for both clinical and diagnostic purpo...

Bio & Pharma Access Bio opens second plant in New Jersey

The US-based in-vitro diagnostic device company Access Bio Inc. announced on Monday that it opened its second factory in Monroe Township, New Jersey...

Artificial intelligence SK C&C AI diagnostic service checks Doosan Enerbility’s plants

SK C&C, a systems integration affiliate of South Korea’s SK Group, on Thursday said it will provide diagnostic services based on generativ...

Bio & Pharma Noul to export $1.4 mn in malaria diagnostic kits to Angola

South Korean in-vitro diagnostics maker Noul Co. has signed an exclusive sales deal in Angola on the company’s malaria diagnostic platform wor...

Bio & Pharma Noul releases AI-based diagnostic gizmo for cervical cancer

Noul Co., a South Korean company specializing in artificial intelligence (AI)-based blood and cancer diagnostic platforms, has entered the cancer di...

Tech, Media & Telecom KT develops network diagnostic solutions

South Korea's KT Corp. has developed a solution called "DX Care" that allows for easy and fast diagnosis of corporate intranet quality issues. KT's ...